Skip to main content

Table 2 Characteristics of study participants at recruitment

From: Association between circulating 25-hydroxyvitamin D concentrations and hip replacement for osteoarthritis: a prospective cohort study

 

Men

Women

Total hip replacement for OA

Total hip replacement for OA

No

Yes

No

Yes

Number of participants

1379

86

1099

87

25(OH)D (nmol/L), median (IQR)

54.5 (42.7-69.0)

57.0 (47.3-66.4)

42.8 (34.7-52.7)

44.6 (34.5-53.3)

25(OH)D Quartile, n (%)

 1 (M < 43.00; F < 34.80 nmol/L)

354 (25.7)

12 (13.9)

279 (25.3)

23 (26.4)

 2 (M 43.00- < 54.85; F 34.80- < 42.92 nmol/L)

346 (25.1)

24 (27.9)

278 (25.3)

19 (21.8)

 3 (M 54.85- < 69.22; F 42.92- < 53.04 nmol/L)

337 (24.4)

31 (36.1)

272 (24.8)

23 (26.4)

 4 (M ≥ 69.22; F ≥ 53.04 nmol/L)

342 (24.8)

19 (22.1)

270 (24.6)

22 (25.3)

Age (years), mean (SD)

53.5 (9.0)

55.4 (8.2)

53.3 (8.6)

56.6 (8.1)

Body mass index (kg/m2), mean (SD)

26.8 (3.5)

28.1 (3.2)

26.1 (5.0)

26.8 (4.4)

Country of birth, n (%)

 Australia/United Kingdom

1129 (81.9)

73 (84.9)

948 (86.3)

79 (90.8)

 Italy/Greece

250 (18.1)

13 (15.1)

151 (13.7)

8 (9.2)

Socioeconomic status (SEIFA), n (%)

 Most deprived (quintiles 1-3)

678 (49.4)

37 (43.0)

475 (43.3)

38 (43.7)

 Least deprived (quintiles 4-5)

694 (50.6)

49 (57.0)

621 (56.7)

49 (56.3)

Vigorous physical activity, n (%)

360 (26.1)

31 (36.1)

269 (24.5)

22 (25.3)

Smoking (former/current), n (%)

766 (55.6)

41 (47.7)

355 (32.3)

34 (39.1)

Diabetes, n (%)

58 (4.9)

2 (2.8)

22 (2.3)

1 (1.3)

Hypertension, n (%)

257 (21.5)

16 (22.5)

212 (21.8)

20 (25.6)

  1. OA osteoarthritis, 25(OH)D 25-hydroxyvitamin D, IQR interquartile range, M male, F female, SD standard deviation, SEIFA Socio-Economic Indexes for Areas